LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Allogene Therapeutics (NASDAQ: ALLO)

Follow NASDAQ:ALLO Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ALLO Allogene Therapeutics
Beneski Benjamin Machinas / officer: SVP, Chief Technical Officer
03/01/2025
Buy
$1.80
112,339
$202K
112,339
NASDAQ ALLO Allogene Therapeutics
Beneski Benjamin Machinas / officer: SVP, Chief Technical Officer
03/01/2025
Sell
$1.94
43,698
$85K
0
NASDAQ ALLO Allogene Therapeutics
Beneski Benjamin Machinas / officer: SVP, Chief Technical Officer
03/01/2025
Sell
$5.04
24,428
$123K
0
NASDAQ ALLO Allogene Therapeutics
Beneski Benjamin Machinas / officer: SVP, Chief Technical Officer
03/01/2025
Sell
$13.31
54,314
$723K
0
NASDAQ ALLO Allogene Therapeutics
Beneski Benjamin Machinas / officer: SVP, Chief Technical Officer
03/01/2025
Sell
$9.69
9,014
$87K
0
NASDAQ ALLO Allogene Therapeutics
MESSEMER DEBORAH M. / director
02/18/2025
Sell
$2.43
13,313
$32K
144,316
NASDAQ ALLO Allogene Therapeutics
Douglas Earl Martin / officer: SVP, General Counsel
02/03/2025
Sell
$1.71
6,404
$11K
587,848
NASDAQ ALLO Allogene Therapeutics
Parker Geoffrey M. / officer: CHIEF FINANCIAL OFFICER
02/03/2025
Sell
$1.73
4,361
$8K
1.30M
NASDAQ ALLO Allogene Therapeutics
MOORE TIMOTHY L. / officer: Chief Technical Officer
02/03/2025
Sell
$1.71
14,746
$25K
250,713
NASDAQ ALLO Allogene Therapeutics
Chang David D / director, officer: President and CEO
02/03/2025
Sell
$1.68
46,003
$77K
5.32M
NASDAQ ALLO Allogene Therapeutics
Roberts Zachary / officer: EVP of R&D
02/03/2025
Sell
$1.70
18,832
$32K
643,135
NASDAQ ALLO Allogene Therapeutics
Douglas Earl Martin / officer: SVP, General Counsel
01/24/2025
Buy
$1.94
512,370
$994K
512,370
NASDAQ ALLO Allogene Therapeutics
Parker Geoffrey M. / officer: CHIEF FINANCIAL OFFICER
01/24/2025
Buy
$1.94
614,844
$1.193M
614,844
NASDAQ ALLO Allogene Therapeutics
Yoshiyama Annie / officer: SVP, Finance
01/24/2025
Buy
$1.94
128,093
$249K
128,093
NASDAQ ALLO Allogene Therapeutics
Roberts Zachary / officer: EVP of R&D
01/24/2025
Buy
$1.94
614,844
$1.193M
614,844
NASDAQ ALLO Allogene Therapeutics
Belldegrun Arie / director
01/24/2025
Buy
$1.94
1.31M
$2.537M
1.31M
NASDAQ ALLO Allogene Therapeutics
Chang David D / director, officer: President and CEO
01/24/2025
Buy
$1.94
1.95M
$3.787M
1.95M
NASDAQ ALLO Allogene Therapeutics
Roberts Zachary / officer: EVP of R&D
01/21/2025
Sell
$1.78
27,199
$48K
488,054

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous